Skip to main navigationSkip to main content
The University of Southampton
Chemistry

Research project: Deep Tissue Chemically Specific Theranostic Imaging for Cancer and Musculoskeletal Diseases

Currently Active: 
Yes

Funded by a Transformative Healthcare 2050 award by the EPSRC titled “Lighting the Way to a Healthy Nation” an interdisciplinary team of Southampton based scientists and researchers are developing novel methodologies and instrumentation that will allow early detection, imaging and treatment deep inside tissues up to several millimetres and ultimately up to several centimetres. The imaging process is aimed to be chemically specific and therefore, highly informative and yet completely non-invasive and non-destructive, whilst providing near instant results. The current target applications are melanoma and musculoskeletal diseases such as osteoarthritis and osteoporosis.

The project is part of a larger cross-institutional team effort wherein new detectors and novel computational methods will be contributed by the University of Edinburgh and the University of Nottingham, respectively. The overall team consists of chemists, biologists, physicists, computer scientists, laser, electronics and biomedical engineers as well as clinicians in a truly collaborative effort to transform the practice of disease diagnosis and treatment at both the community and specialist healthcare level.

Southampton award value: £2,468,274

Related Southampton Staff: Prof Sumeet Mahajan from Chemistry (Southampton PI), Prof David Richardson from the ORC and Prof Richard Oreffo from Medicine

Early Career Researchers involved: Dr Konstantinos Bourdakos, Dr Jonathan Price, Dr Anna Crisford, Hiroki Cook.

Share this research project Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings